Company / Free Cash Flow per Share
ENDONOVO THERAPEUTICS, INC. Free Cash Flow per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$5.90
FY2019
5-year range
-$5.90 / -$0.01
FY2015-FY2019
Trend
-64664.0%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -64664% YoY in FY2019, a notable deviation from the 3-year average annual change of -21513%.
Based on SEC 10-K filings.
-5.90 in FY2019.
Declined from $-0.01 to $-5.90 over the past 4 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, free cash flow per share decreased 64664.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$5.90 | -64664.0% |
| FY2018 | -$0.01 | - |
| FY2016 | - | - |
| FY2015 | -$0.01 | +98.8% |
| FY2014 | -$1.09 | - |
| FY2011 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 29, 2026